Abstract-Objective: Most automatic cuff blood pressure (BP) measurement devices are based on oscillometry. These devices estimate BP from the envelopes of the cuff pressure oscillations using fixed ratios. The values of the fixed ratios represent population averages, so the devices may only be accurate in subjects with normal BP levels. The objective was to develop and demonstrate the validity of a patient-specific oscillometric BP measurement method. Methods: The idea of the developed method was to represent the cuff pressure oscillation envelopes with a physiologic model, and then estimate the patient-specific parameters of the model, which includes BP levels, by optimally fitting it to the envelopes. The method was investigated against gold standard reference BP measurements from 57 patients with widely varying pulse pressures. A portion of the data was used to optimize the patient-specific method and a fixed-ratio method, while the remaining data were used to test these methods and a current office device. Results: The patient-specific method yielded BP root-mean-square-errors ranging from 6.0 to 9.3 mmHg. On an average, these errors were nearly 40% lower than the errors of each existing method. Conclusion: The patient-specific method may improve automatic cuff BP measurement accuracy. Significance: A patient-specific oscillometric BP measurement method was proposed and shown to be more accurate than the conventional method and a current device.
I. INTRODUCTION
O SCILLOMETRY is a widely used approach for automatic cuff blood pressure (BP) measurement [1] - [3] . In this approach, a cuff placed on the upper arm is inflated and then deflated while the pressure inside the cuff is measured. As shown in Fig. 1 , the resulting cuff pressure not only rises and falls but also shows small oscillations, indicating the pulsatile blood volume within the brachial artery underneath the cuff. The amplitude of these oscillations changes with the applied cuff pressure, as the brachial artery compliance varies with transmural pressure (i.e., BP-cuff pressure). BP is then estimated from the oscillation amplitudes and cuff pressure.
The BP estimation is conventionally performed via fixed ratios [1] , [2] , [4] . As shown in Fig. 1 , first, mean BP (MP) is estimated as the cuff pressure at which the oscillation amplitude is maximal, since the brachial artery compliance peaks near the zero transmural pressure. Then, systolic and diastolic BP (SP and DP) are each estimated as the cuff pressure at which the oscillation amplitude is some fixed ratio of the maximal value. While current devices do not disclose their exact methods for estimating the BP, they are believed to employ the fixed-ratio method or some variant thereof [1] , [2] , [5] . Since such methods are based on population averages, the devices may only work well in the subjects with normal BP levels. Indeed, the accuracy of the devices is known to be compromised in subjects with large artery stiffening and, thus, high pulse pressure (PP = SP − DP) [2] , [5] -a common condition that occurs with aging and disease.
In this study, we developed a patient-specific method to estimate BP from the oscillometric cuff pressure waveform. The basic idea is to represent the oscillation amplitudes and cuff pressure with a physiologic model, and then estimate the patient-specific parameters of the model, which includes BP levels, by optimally fitting it to the measured data. We tested the method against gold standard reference BP measurements in patients referred for diagnostic cardiac catheterization-a population with widely varying PP. Our results indicate that the patient-specific method can afford greater BP estimation accuracy than the fixed-ratio method, and a current device used for the hypertension management in the office. A preliminary version of this study has been reported in the abbreviated form [6] .
II. PATIENT-SPECIFIC OSCILLOMETRIC BP MEASUREMENT METHOD
The proposed method was inspired by Drzewiecki et al., who established a model to explain oscillometry [7] . Similar to available methods, a standard oscillometric cuff pressure waveform is obtained; the difference in the upper and lower envelopes of the oscillations (i.e., the high-pass filtered or ac waveform) as a function of the cuff pressure (i.e., the unfiltered waveform) is computed during the inflation or deflation period (whichever is longer); and BP is estimated from this oscillation amplitude versus cuff pressure function. However, in contrast to the available methods, the BP estimation is based on a physiologic model and is, thus, patient-specific.
This novel BP estimation is implemented in four steps. First, the oscillation amplitude versus cuff pressure function is represented using a parametric model of the nonlinear brachial artery blood volume-transmural pressure relationship. Second, the model is optimally fitted to the measured function to estimate its unknown parameters, including SP and DP. Third, the blood volume waveform is constructed using the parameter estimates and cuff pressure oscillations. Fourth, the BP waveform is derived by applying the blood volume and cuff-pressure waveforms to the patient-specific brachial artery blood volumetransmural pressure relationship, and MP is computed from the derived waveform. These steps are fully summarized in Figs. 2 and 3, and further described below.
In the first step (see Fig. 2 ), the oscillation amplitude versus cuff-pressure function is represented using a parametric model of the nonlinear brachial artery blood volume-transmural pressure relationship. This model assumes a sigmoidal relationship as justified by experimental data [7] , [8] and is, in particular, based on a left-shifted, Fisk cumulative probability distribution function [9] as follows:
Here, t is time; V a (t) is the blood volume waveform; P a (t) is the BP waveform; P c (t) is the unfiltered cuff-pressure waveform; and a, b, c, and d characterize brachial artery mechanics. In terms of the brachial artery compliance curve, which is simply the derivative of (1) with respect to transmural pressure [P a (t) − P c (t)], a (units of mmHg) denotes the transmural pressure at which the curve is maximal; b (units of mmHg), and c (unitless) reflect the width of the curve and the degree of asymmetry about its maximum; and d (units of cm 3 ) determines the Fig. 3 . Proposed patient-specific method for estimating BP from the oscillometric cuff-pressure waveform (cont.). The last two steps of the method use the parameter estimates from the first two steps to ultimately yield an estimate for MP. The left-most plot here and the three right-most plots in Fig. 2 were simulated by a mathematical model of oscillometry [7] for illustrative purposes.
amplitude of the curve. Note that (1) is only valid over the range specified by (P a (t) − P c (t) − a) + b((c − 1)/(c + 1)) 1/c > 0. This model can directly represent a blood volume versus cuffpressure function. That is, the upper and lower envelopes of the blood volume waveform as a function of cuff pressure may be represented with the above model by setting P a (t) to SP and DP, respectively (see right plot in Fig. 2 , where the abscissae are specifically given by the negative of the unfiltered cuffpressure waveform). However, the blood volume waveform is not measured.
In order to apply the model to the measured cuff-pressure waveform, two approximations are made. First, the difference in the upper and lower envelopes of the blood volume waveform as a function of negative cuff pressure is essentially equivalent to the difference in the upper and lower envelopes of the blood volume oscillations (i.e., the high-pass filtered blood volume waveform) as a function of negative cuff pressure (compare right and upper plots in Fig. 2) . Second, the cuff pressure-air volume relationship of actual cuffs is nearly linear over a wide range (see left plot in Fig. 2 ) [7] . So, the unmeasured blood volume oscillations may be proportional to the measured cuffpressure oscillations (see upper and lower plots in Fig. 2 ) with a proportionality constant equal to k, which indicates the reciprocal of the compliance of the cuff. Note that these oscillations do not include the x-intercept of the cuff pressure-air volume relationship, as they are derived via high-pass filtering.
Putting the above model and approximations together, the measured oscillation amplitude versus cuff-pressure function is precisely represented with the model as follows:
where P oa c (t) is the cuff-pressure oscillation amplitude waveform and e = k · d (units of mmHg). P oa c (t) and P c (t) are derived from the measured oscillometric cuff-pressure waveform and, thus, known, whereas a, b, c, e, SP, and DP are patientspecific parameters and, thus, unknown.
In the second step (see Fig. 2 ), the unknown parameters are estimated by optimally matching both sides of (2) to each other in the least squares sense. In particular, the following optimization problem is solved:
Hence, the first two steps produce estimates for SP and DP. The last two steps yield an estimate for MP as follows.
In the third step (see Fig. 3 ), a scaled blood volume waveform [kV a (t)] is constructed using the parameter estimates. The idea is to construct (to within a scale factor) the right-most plot in Fig. 2 , which indicates the blood volume waveform, by adding the cuff-pressure oscillations to the lower envelope in this plot, which may be derived from the parameter estimates. More specifically and referring back to Fig. 3 , the lower envelope of the cuff-pressure oscillations as a function of negative cuff pressure (second plot from left) is subtracted from the cuff-pressure oscillations as a function of negative cuff pressure (left-most plot). The resulting positive amplitude oscillations as a function of negative cuff pressure (middle plot) are then summed to a function defined by the model of (1) scaled by k with the parameter estimates for a, b, c, and e and P a (t) set to the DP estimate (second plot from right). The ordinates of the function resulting from these simple operations specify the scaled blood volume waveform (see right-most plot; compare to right-most plot in Fig. 2 ). Note that the scaled blood volume waveform may also be analogously obtained from the upper envelope.
In the fourth step (see Fig. 3 ), the BP waveform is derived using the scaled blood volume waveform according to the model of (1) scaled by k. In particular, for each t, all quantities in this equation are known, except for P a (t). Hence, BP is derived at each time instance by finding the root of the equation. Finally, the time average of the constructed BP waveform is computed so as to yield an estimate for MP.
III. MATERIAL AND METHODS
The patient-specific oscillometric BP measurement method was investigated using data comprising the oscillometric cuffpressure waveforms for the analysis and gold standard reference BP measurements from human subjects covering a wide PP range. These data were divided into distinct training and testing sets. While the proposed method is patient-specific, a training dataset was still needed to define its detailed aspects, including the values of its user-selected variables. The training dataset was also utilized to establish a conventional fixed-ratio method. The testing dataset was utilized to assess the accuracy of the patient-specific method, and to compare its performance to the fixed-ratio method as well as a current device. Details follow.
A. Patient Data
Patients admitted to the Taipei Veterans General Hospital (Taiwan) were studied under IRB approval and with adherence to the principles of the Declaration of Helsinki. The patient characteristics and study procedures are described in detail elsewhere [10] , [11] . Information relevant to the present study is briefly described below.
Sixty patients referred for the diagnostic cardiac catheterization were included. These patients (63 ± 14 years, 77% males) had clinical diagnoses of mainly hypertension (68% of the patients), coronary artery disease (65%), dyslipidemia (44%), and/or diabetes (33%) and were on various medications. All patients had normal sinus rhythm, and none of the patients showed an interarm BP difference of more than 3 mmHg.
A micromanometer-tipped catheter (SPC-320, Millar Instruments, USA) was placed in a brachial artery to measure the gold standard reference BP waveform. An oscillometric BP cuff (WatchBP Office, Microlife AG, Switzerland or VP-1000, Omron Colin, Japan) was placed over the opposite brachial artery to measure the oscillometric cuff-pressure waveform for analysis as well as to document the SP, MP, and DP estimates of the Microlife or Omron device. The waveforms were simultaneously recorded at a sampling rate of 250 Hz. In many patients, the measurements were likewise recorded after the administration of sublingual nitroglyercin to reduce BP.
B. Data Analysis
The data for study were divided into a training set comprising 40 of the patient records and a testing set consisting of the remaining 20 patient records. The patient records in each dataset were randomly selected. All oscillometric cuff-pressure waveforms in the two datasets were essentially artifact-free based on visual inspection. However, the fidelity of the reference BP waveforms in three of the patient records in the training dataset was questionable. These patient records were excluded from further analysis yielding a total of 57 patient records for analysis.
The training dataset was first analyzed. More specifically, the patient-specific method was fully defined by the minimization of the average of the root-mean-square-error (RMSE) between the SP estimate and reference SP and the RMSE between the DP estimate and reference DP in this dataset. The method that resulted was actually slightly suboptimal but potentially more robust. This method was implemented as follows. First, the upper and lower envelopes of the oscillations as a function of cuff pressure were identified by detecting the maximum and minimum of each beat, applying a median filter to the maxima and minima to remove the respiratory contamination, and linearly interpolating between the filtered maxima and minima. Then, the difference between these envelopes, which is the oscillation amplitude versus cuff-pressure function, was represented with the physiologic model of (2) . Next, the unknown model parameters were estimated by solving the optimization problem of (3), but with constraints on the parameters. The parameter constraints included imposing the valid range of (1) and setting a, which denotes the peak position of the brachial artery compliance curve, to near 0 mmHg and fixing the value of b for each value of c, such that the curve is right-skewed by 35% about its peak. Note that the peak position of the compliance curve is not an identifiable parameter, but may be near zero transmural pressure anyhow, and that the compliance curve may indeed be typically right-skewed due to the differences in collapsed and distended artery mechanics [7] . Also, note that fixing the c and d parameters in addition to a and b parameters degraded the BP estimation accuracy, thereby suggesting that a patient-specific brachial artery blood volume-transmural pressure relationship was necessary. The four-parameter constrained optimization problem was specifically solved using sequential quadratic programming [12] to yield estimates for SP, DP, and the other parameters. The parameter estimates were generally unique as ascertained via multiple initial seeds. Finally, MP was estimated as outlined in detail in Section II. Values are average ± standard deviation (range). SP, MP, and DP are systolic, mean, and diastolic BP, respectively, and PP is pulse pressure.
TABLE II BP ERROR METRICS FOR THE PATIENT-SPECIFIC METHOD AND EXISTING METHODS IN THE TRAINING DATASET
A fixed-ratio method was also established using the training dataset. That is, after estimating MP via the cuff pressure at which the oscillation amplitude is maximal, values of fixed ratios for SP and DP were defined by minimizing the RMSE between the SP and DP estimates and their reference values.
The optimal values that resulted were 0.55 for SP and 0.78 for DP, which are consistent with previous reports [2] , [4] , [7] .
The testing dataset was then analyzed. First, the patientspecific and fixed-ratio methods were applied to the ocillometric cuff-pressure waveforms. Then, the SP, MP, DP, and PP estimates of these methods as well as the Microlife or Omron device were assessed against their reference values via the standard bias error (i.e., mean of the errors) [μ] and precision error (i.e., standard deviation of the errors) [σ] as well as the RMSE (i.e., total magnitude of the errors) [ = Ý(μ 2 +σ 2 )]. Finally, the bias and precision errors of the patient-specific method were compared to those of the existing methods using the paired t-test and Pitman-Morgan test [13] , respectively. Similar results from the training dataset were also obtained excluding the statistical comparisons with the current device, which, unlike the other two methods, was not optimized with respect to this dataset.
In both datasets, reference SP and DP were specifically computed by detecting the maximum and minimum of each beat of the simultaneously recorded invasive BP waveform during the cuff deflation period (typically about 20 s), and then averaging the respective values over the beats. Reference MP was computed as the time average of the invasive BP waveform during the same period.
IV. RESULT Table I shows the average, standard deviation, and range of reference SP, MP, DP, and PP before and after the nitroglycerin administration in the combined training and testing datasets. These BP statistics were similar between the two datasets. The average of baseline SP was close to hypertensive levels, whereas the average of baseline DP was at normotensive levels. Hence, the average of baseline PP was high. Nitroglycerin reduced the average of SP, which impacted the averages of MP and PP. The standard deviations of PP and SP were highest and near 20 mmHg. PP and SP ranged from normal to high levels, so a number of the patients may not have had large artery stiffening. Table II shows the SP, MP, DP, and PP bias and precision errors for the patient-specific and fixed-ratio methods, as well as the Microlife device in the training dataset. The patient-specific method produced small bias errors and precision errors of 5.0 to 8.1 mmHg. The fixed-ratio method yielded similar bias errors but higher precision errors of 7.5 to 13.2 mmHg (p < 0.05). Although it may not be fair to compare the Microlife device to these two methods in the training dataset, it is noted that the device did show higher bias and precision errors than the patientspecific method. If the opposite were true, then the current device would be clearly superior. Table III shows the same quantitative BP error metrics for the two methods and the Omron device in the testing dataset, while Fig. 4 shows the Bland-Altman plots of these three methods in this dataset, so that their accuracy can be visually assessed and compared. The patient-specific method achieved bias errors of 2.6 to 5.3 mmHg in magnitude and precision errors of 5.0 to 7.7 mmHg. The fixed-ratio method showed significantly different bias errors (p < 0.05), with higher magnitudes of 3.8 to 8.6 mmHg and larger precision errors of 8.4 to 14.0 mmHg (p < 0.05). The Omron device yielded larger bias error magnitudes of 6.0 to 11.0 for MP, DP, and PP than the patient-specific method (p < 0.05), and larger precision errors of 8.9 and 11.5 mmHg for SP and MP than this method (p < 0.10 or p < 0.05). These two methods showed precision errors for PP that did not statistically differ. However, the patient-specific method produced two large absolute errors for PP (see Fig. 4 ), which substantially compromised its precision error. Indeed, after removing the bias component, the percent of PP errors >5 and >10 mmHg were 40% and 11% for the patient-specific method, but 75% and 25% for the Omron device. In this quantitative sense, the PP precision accuracy of the patient-specific method was superior to the current device. Overall, the average RMSE of the patient-specific method was 7.3 mmHg, which was about 40% smaller than the corresponding RMSE of each existing method. The improved accuracy afforded by the patient-specific method was significant for all four BP estimates. In addition, the patientspecific method showed BP errors that were least correlated with the reference BP values. Over the combined training and testing datasets, the patientspecific method yielded model parameter estimates that were distributed (mean ± SD) as follows: a = 2.5 mmHg, b = 73.3 ± 30.0 mmHg, c = 5.5 ± 0.9 unitless, and e = 8.2 ± 1.5 mmHg. The c and e parameters were 5.2 ± 0.6 unitless and 8.3 ± 1.4 mmHg before nitroglycerin administration and 5.9 ± 1.0 unitless and 8.9 ± 1.5 mmHg after nitroglycerin administration, respectively (p < 0.05 via paired t-tests). These significant c and e increases following nitroglycerin administration correspond to enhanced brachial artery compliance. So, the patient-specific method predicted vascular changes consistent with the known effect of the drug.
The BP estimation accuracy of the method was, therefore, not impacted by nitroglycerin administration but neither was the accuracy of the existing methods (results not shown).
V. DISCUSSION
In summary, we conceived a method to estimate BP from the oscillometric cuff-pressure waveform. While current methods may perform the BP estimation based on population averages (see Fig. 1 ), the proposed method leverages a physiologic model in combination with the optimization to achieve patient-specific BP estimation (see Figs. 2 and 3) . In this way, automatic cuff BP measurement accuracy may potentially be maintained over a wide range of BP levels.
We investigated the patient-specific method against gold standard reference BP measurements via a high-fidelity brachial artery catheter from 57 patients, whose PP and SP ranged from normal to very high levels (see Table I ). We used 65% of the data to develop or train the method and the remaining 35% of the data to test it.
The patient-specific method yielded SP, MP, DP, and PP estimates with bias error magnitudes between 2.6 and 5.3 mmHg and precision errors between 5.0 and 7.7 mmHg for an overall average RMSE of 7.3 mmHg in the testing dataset (see Table III and Fig. 4) . The corresponding RMSE of the method in the training dataset was 1.2 mmHg lower (see Table II ). The accuracy of the method in the testing dataset was well within the AAMI limits of 5 and 8 mmHg bias and precision errors for SP, MP, and DP and close to these limits for PP; however, these results were not obtained with an AAMI data collection protocol [14] .
There are several potential sources of the BP estimation error of the method. First, the underlying physiologic model ignores arm tissue compressibility and brachial artery wall viscoelasticity. However, the compressibility of tissue around zero transmural pressure, which is most crucial in oscillometry and typically amounts to an applied cuff pressure of about 100 mmHg, may not be that significant, as it is largely compressed already. Furthermore, the wall viscosity of the muscular, but mediumsized, brachial artery may not be that significant compared to its elasticity as argued elsewhere [15] . Secondly, the oscillometric cuff-pressure waveforms that were available for analysis were either converted from volts to mmHg with inexact calibration information in the case of the training dataset (Microlife device), or did not include a high resolution (low quantization error) ac component in the case of the testing dataset (Omron device). Hence, if the waveforms were of higher quality, the method could possibly have yielded lower errors. Finally, the method assumes that cuff-pressure oscillations are proportional to blood volume oscillations and, thus, neglects the nonlinearity of the arm cuff pressure-volume relationship. However, cuff nonlinearity is greatest at low cuff pressures (see left plot of Fig. 2) , and the patients for study were not hypotensive (see Table I ). So, unlike the other potential error sources, we do not believe that cuff nonlinearity was a major contributor to the error.
For comparison, we also investigated the conventional fixedratio method (see Fig. 1 ) by establishing the fixed ratio values using the training dataset and assessing the method in the testing dataset. The overall average RMSE of the method was 9.9 mmHg in the training dataset and 12.1 mmHg in testing dataset (see Tables II and III and Fig. 4) . Hence, the patient-specific method reduced the BP estimation error of the conventional method by about 40% in each dataset. The error reduction was achieved mainly via lower precision errors for all four BP estimates. This comparison was apples-to-apples. That is, not only were the analyzed oscillometric cuff-pressure waveforms and training and testing datasets the same, but also the oscillation amplitude versus cuff-pressure functions from which BP was estimated.
In addition, we included the BP estimates of a device designed for hypertension management in the office rather than for home monitoring of normal subjects (Microlife or Omron). The overall average RMSE of the device was 11.3 mmHg in the training dataset (see Microlife in Table II ) and 11.6 mmHg in the testing dataset (see Omron in Table III and Fig. 4) . Hence, the patientspecific method reduced the BP estimation error of a current device by 37% in the more meaningful testing dataset. The error reduction was achieved via lower bias errors for MP, DP, and PP and lower precision errors for SP and MP. Also, though not reflected in these error metrics, the patient-specific method achieved substantially better precision accuracy for PP, which is a more powerful predictor of cardiovascular outcomes in the elderly than SP [16] . However, this comparison was not exactly apples-to-apples. In particular, the oscillometric cuff-pressure waveforms analyzed by the Microlife and Omron devices were surely well calibrated and of high resolution. So, the device benefitted from higher quality waveforms for analysis than the other two methods. The device also must have derived different oscillation amplitude versus cuff-pressure functions to estimate BP. We suspect that the device performs this initial step, which can also impact the accuracy, quite well.
We utilized the most accurate reference BP measurement method available, namely micromanometer-tipped brachial artery catheterization. For practical reasons, invasive BP has not been assessed as a predictor of risk for stroke and heart disease. Rather, noninvasive BP via auscultation (i.e., manual cuff BP measurement using a stethoscope and mercury manometer) is the proven cardiovascular risk factor [17] . However, auscultation is not as accurate as invasive BP due to various factors, including operator error and the well-known auscultatory gap [18] . It may, thus, be reasonable to assume that invasive BP would constitute a superior predictor of stroke and heart disease. In this sense, the improved accuracy of the patient-specific method shown here may be particularly significant.
Nevertheless, because noninvasive BP via auscultation is the proven cardiovascular risk factor and for practical reasons, most, if not all, BP estimation methods of current office and home devices are built from data using auscultation as the reference [3] , [19] . The Microlife and Omron devices studied herein were likely built to predict the auscultation BP. There are systematic differences between invasive SP and auscultation SP as well as invasive DP and auscultation DP [14] . These differences could at least partly explain the higher bias error magnitudes of the current device (see Tables II and III) . However, even if the bias errors were ignored altogether, the patient-specific method still attained precision errors that were 25% lower for SP and 57% lower for MP than the current device, while reducing PP errors >5 and 10 mmHg by 52% compared to this device.
We believe that the inclusion of 57 patients for the study is not insignificant. Furthermore, even after dividing the patient records into training and testing sets, the improved accuracy of the patient-specific method over the competing methods was statistically significant. Still, the main limitation of this study is the 20 patient sample size of the testing dataset. Future studies are needed in a larger cohort of subjects to fully assess the accuracy of the proposed method relative to existing methods.
VI. CONCLUSION
Most automatic cuff BP measurement devices estimate BP from an oscillometric cuff-pressure waveform, using population average methods. Hence, these devices may only be accurate over the normal BP range. In this study, we developed a patient-specific method to estimate BP from the same oscillometric cuff-pressure waveform. The underlying idea is to represent the waveform with a physiologic model, and then, to estimate the patient-specific model parameters by optimally fitting the model to the waveform. We demonstrated that this method can appreciably improve the accuracy over the state-ofthe-art in patients with widely varying PP using gold standard invasive BP as a reference. Future studies may be worthwhile in a larger and more diverse cohort of subjects to fully assess the capabilities and limitations of the method relative to the existing methods. With further successful testing, the patientspecific method could possibly improve the automatic cuff BP measurement, and thereby facilitate hypertension management in both low and high resource settings.
